Safety and Immunogenicity of a PHH-1V Booster Dose after Different Prime Vaccination Schemes against Covid-19: Phase III Clinical Trial Final Results Up To One Year. (2024). Archives of Clinical and Biomedical Research, 8(4), 326-342. https://fortunejournals.org/ojs/index.php/acbr/article/view/15082